According to a new study first reported on by NORML and published in the journal Discoveries, the daily administration of whole-plant cannabis oil is associated with a significant improvement in symptoms of anxiety and vertigo.
For the case report an Australian investigator reported on the successful use of cannabis oil for symptom management in an 88-year-old female patient with generalized anxiety disorder and debilitating vertigo. The patient reported “significant improvements in her quality of life” following four weeks of daily cannabis use (2 ml of THC-dominant oil). The subject reported that her nausea, dizziness, and limited mobility returned shortly after she stopped taking cannabis oil. Symptoms ceased when she once again reintegrated cannabis oil into her daily treatment regimen.
The report’s author concluded: “[T]his case demonstrates how the patient was able to significantly benefit from the introduction of medical cannabis into her mental health intervention for the treatment of vertigo and a generalized anxiety disorder. In this case, the benefits for the 88-year-old patient using medical cannabis as a treatment in the both the short term and longer-term far outweighed the potential risks that may require consideration for children or adolescents.”
The abstract of the report can be found below:
Despite the increasing prevalence and acceptance of
the medical cannabis use among the general public,
the evidence required by physicians to use cannabis
as a treatment is generally lacking. Research on the
health effects of cannabis and cannabinoids has been
limited worldwide, leaving patients, health care
professionals, and policymakers without the
evidence they need to make sound decisions
regarding the use of cannabis and cannabinoids. This
case study outlines an intervention that involved a
patient integrating medical cannabis into her
treatment to better manage a generalized anxiety
disorder and the debilitating symptoms of vertigo.
This case demonstrates how the patient drastically
improved her quality of life and reinforces the need
for more rigorous testing on the use of medical
cannabis to support patients and better manage the
symptoms associated with their medical conditions